These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30692202)

  • 21. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
    Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
    Williams K; Motiani K; Giridhar PV; Kasper S
    Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
    Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
    Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
    Ryoo IG; Choi BH; Ku SK; Kwak MK
    Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.
    Biddle A; Gammon L; Fazil B; Mackenzie IC
    PLoS One; 2013; 8(2):e57314. PubMed ID: 23437366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
    Iczkowski KA; Omara-Opyene AL; Shah GV
    Anticancer Res; 2006; 26(4B):2863-72. PubMed ID: 16886606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.
    Wang W; Zhang H; Liu S; Kim CK; Xu Y; Hurley LA; Nishikawa R; Nagane M; Hu B; Stegh AH; Cheng SY; Cheng C
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8366-8371. PubMed ID: 28716909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop.
    Liu S; Cheng C
    Cancer Res; 2017 Jul; 77(14):3791-3801. PubMed ID: 28533273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
    Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
    PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESRP1-Induced CD44 v3 Is Important for Controlling Pluripotency in Human Pluripotent Stem Cells.
    Kim YD; Kim HS; Lee J; Choi JK; Han E; Jeong JE; Cho YS
    Stem Cells; 2018 Oct; 36(10):1525-1534. PubMed ID: 29873154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.
    Hiraga T; Nakamura H
    Oncol Lett; 2016 Oct; 12(4):2962-2969. PubMed ID: 27698884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.